Bambusa Therapeutics, Inc. Common Stock

BBTX

Börsenwert 801 Mio. $

15,73 USD

-0,12

0,76 %

Zum Börsenschluss Aktualisiert 6. Nov., 16:00 EST

1 Tag

-0,76 %

5 Tage

4,94 %

1 Monat

4,94 %

3 Monate

4,94 %

6 Monate

4,94 %

Seit Jahresbeginn

4,94 %

1 Jahr

4,94 %

5 Jahre

4,94 %

10 Jahre

4,94 %

Profil: Bambusa Therapeutics Inc is a clinical-stage biotechnology company developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases.

Gesundheitswesen Biotechnologie

Nachrichten

Positiv

Neutral

Negativ

Stimmung 3 Monate

Positiv 0 %

Neutral 100 %

Negativ 0 %

Neutral

Seeking Alpha

vor 8 Tagen

U.S. IPO Weekly Recap: Anthropic Files For Potentially Record-Breaking IPO

Three IPOs, one direct listing, and two SPACs priced during a challenging week for growth stocks. Just one SPAC is currently scheduled to list in the week ahead, although some smaller deals may also join the calendar throughout the week. Street research is expected for two companies in the week ahead, and six lock-up periods will be expiring.

Nachrichtenrankings ansehen

Kursdiagramme mit Lightweight Charts™ umgesetzt

Bambusa Therapeutics, Inc. Common Stock BBTX Börsenwert 801 Mio. $

Nachrichten

Bambusa Therapeutics, Inc. Common Stock

BBTX

Börsenwert 801 Mio. $